Literature DB >> 21217085

Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.

Anna E Prizment1, Kristin E Anderson, Kala Visvanathan, Aaron R Folsom.   

Abstract

BACKGROUND: Chronic inflammation has been implicated in the etiology of colorectal cancer (CRC), but epidemiologic findings on the association between circulating inflammatory markers and CRC risk are inconsistent. We hypothesized that increased concentrations of systemic inflammatory markers-white blood cell count (WBC), fibrinogen, von Willebrand factor (VWF), factor VIII (FVIII), and C-reactive protein (CRP)-and decreased albumin concentration would be associated with increased CRC risk in the Atherosclerosis Risk in Communities prospective cohort.
METHODS: WBC, fibrinogen, VWF, FVIII, and albumin, measured in 1987-1989 in 13,414 men and women, were transformed to z-scores and summed up to construct a blood "inflammation z-score." Albumin was included with a negative sign, because its concentration decreases with greater inflammation. A total of 308 incident CRC cases were identified through 2006 in initially cancer-free participants. CRP was measured in 1996-1998 in 9,836 cancer-free people who developed 166 CRCs through 2006. Proportional hazard models were used to estimate the HR and 95% CI of CRC in relation to each individual marker and the inflammation z-score.
RESULTS: After multivariate adjustment, for the highest versus lowest quartile, there was a statistically significant positive association of CRC risk with fibrinogen: HR = 1.50 (95% CI, 1.05-2.15), P = 0.03; inflammation z-score: HR = 1.65 (95% CI, 1.15-2.35), P = 0.01; and CRP: HR = 1.97 (95% CI, 1.13-3.43, P = 0.02.
CONCLUSIONS: These findings indicate that greater levels of fibrinogen, CRP, and blood inflammation z-score are associated with increased CRC risk. IMPACT: The study provides further evidence that precancer inflammation may contribute to CRC etiology. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21217085      PMCID: PMC3169294          DOI: 10.1158/1055-9965.EPI-10-1146

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  48 in total

1.  Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared.

Authors:  Jonathan M Rhodes; Barry J Campbell
Journal:  Trends Mol Med       Date:  2002-01       Impact factor: 11.951

2.  Conversion of human colonic adenoma cells to adenocarcinoma cells through inflammation in nude mice.

Authors:  F Okada; T Kawaguchi; H Habelhah; T Kobayashi; H Tazawa; N Takeichi; T Kitagawa; M Hosokawa
Journal:  Lab Invest       Date:  2000-11       Impact factor: 5.662

3.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

4.  Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987.

Authors:  Wolfgang Koenig; Malte Sund; Margit Fröhlich; Hannelore Löwel; Winston L Hutchinson; Mark B Pepys
Journal:  Am J Epidemiol       Date:  2003-08-15       Impact factor: 4.897

5.  Serum albumin and colorectal cancer risk.

Authors:  P Knekt; T Hakulinen; A Leino; M Heliövaara; A Reunanen; R Stevens
Journal:  Eur J Clin Nutr       Date:  2000-06       Impact factor: 4.016

6.  C-reactive protein and the risk of incident colorectal cancer.

Authors:  Thomas P Erlinger; Elizabeth A Platz; Nader Rifai; Kathy J Helzlsouer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

Review 8.  Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy.

Authors:  Mairi Macarthur; Georgina L Hold; Emad M El-Omar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-04       Impact factor: 4.052

Review 9.  At the crossroads of inflammation and cancer.

Authors:  Hans Clevers
Journal:  Cell       Date:  2004-09-17       Impact factor: 41.582

Review 10.  Contribution of the hemostatic system to angiogenesis in cancer.

Authors:  Marek Z Wojtukiewicz; Ewa Sierko; Janusz Rak
Journal:  Semin Thromb Hemost       Date:  2004-02       Impact factor: 4.180

View more
  32 in total

1.  C-reactive protein and risk of colorectal adenoma according to celecoxib treatment.

Authors:  Andrew T Chan; Camelia S Sima; Ann G Zauber; Paul M Ridker; Ernest T Hawk; Monica M Bertagnolli
Journal:  Cancer Prev Res (Phila)       Date:  2011-08

2.  Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention guidelines and colorectal cancer incidence among African Americans and whites: The Atherosclerosis Risk in Communities study.

Authors:  Guillaume Onyeaghala; Anna K Lintelmann; Corrine E Joshu; Pamela L Lutsey; Aaron R Folsom; Kimberly Robien; Elizabeth A Platz; Anna E Prizment
Journal:  Cancer       Date:  2019-12-24       Impact factor: 6.860

3.  Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC).

Authors:  Anna E Prizment; Amy M Linabery; Pamela L Lutsey; Elizabeth Selvin; Heather H Nelson; Aaron R Folsom; Timothy R Church; Charles G Drake; Elizabeth A Platz; Corinne Joshu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02-05       Impact factor: 4.254

4.  Inverse association of eosinophil count with colorectal cancer incidence: atherosclerosis risk in communities study.

Authors:  Anna E Prizment; Kristin E Anderson; Kala Visvanathan; Aaron R Folsom
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-08       Impact factor: 4.254

5.  Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.

Authors:  Adetunji T Toriola; Ting-Yuan D Cheng; Marian L Neuhouser; Mark H Wener; Yingye Zheng; Elissa Brown; Joshua W Miller; Xiaoling Song; Shirley A A Beresford; Marc J Gunter; Marie A Caudill; Cornelia M Ulrich
Journal:  Int J Cancer       Date:  2012-12-05       Impact factor: 7.396

6.  Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.

Authors:  Mingyang Song; Raaj S Mehta; Kana Wu; Charles S Fuchs; Shuji Ogino; Edward L Giovannucci; Andrew T Chan
Journal:  Cancer Prev Res (Phila)       Date:  2015-10-28

7.  Smoking behavior and lung cancer in a biracial cohort: the Atherosclerosis Risk in Communities study.

Authors:  Anna E Prizment; Hiroshi Yatsuya; Pamela L Lutsey; Jay H Lubin; Mark Woodward; Aaron R Folsom; Rachel R Huxley
Journal:  Am J Prev Med       Date:  2014-06       Impact factor: 5.043

8.  Associations between adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and biomarkers of inflammation, hormonal, and insulin response.

Authors:  Fred K Tabung; Teresa T Fung; Jorge E Chavarro; Stephanie A Smith-Warner; Walter C Willett; Edward L Giovannucci
Journal:  Int J Cancer       Date:  2016-11-14       Impact factor: 7.396

9.  The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation.

Authors:  Corinne E Joshu; Kostantinos K Tsilidis; Sarah B Peskoe; Francis M Giardiello; Paul J Dluzniewski; William G Nelson; Christine A Iacobuzio-Donahue; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2014-01-17       Impact factor: 2.506

10.  A prospective follow-up study of the relationship between C-reactive protein and human cancer risk in the Chinese Kailuan Female Cohort.

Authors:  Gang Wang; Ni Li; Sheng Chang; Bryan A Bassig; Lanwei Guo; Jiansong Ren; Kai Su; Fang Li; Shuohua Chen; Shouling Wu; Yuhuan Zou; Min Dai; Tongzhang Zheng; Jie He
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-09       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.